Shanghai Pharmaceuticals Holding Co Ltd (2607)

Hong Kong


Symbol		Exchange		Currency
2607	·	Hong Kong	·	HKD	Delayed
601607	·	Shanghai	·	CNY	Delayed
SHPMY	·	OTC Markets	·	USD	Delayed

Currency in HKD

11.90

+0.03(+0.25%)

Closed·03:59:59

Fair Value

Unlock Value

Day's Range

11.75

11.97

52 wk Range

10.96

12.93

2607 Income Statement

Assess the Shanghai Pharma Holding income statement, providing a detailed view of the company’s financial performance across activities. This statement outlines key financial figures such as revenue, expenses, operating income, and net income. Assess the 2607 net worth.

Period Ending:

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

2025

31/12

Total Revenues

aa.aa

215,824.26

231,981.3

260,295.09

275,250.93

283,579.6

Total Revenues Growth

aa.aa

+12.46%

+7.49%

+12.21%

+5.75%

+3.03%

Cost Of Revenues

aa.aa

187,416.38

201,604.21

229,365.61

244,837.47

253,206.92

Gross Profit

aa.aa

28,407.88

30,377.09

30,929.48

30,413.47

30,372.68

Gross Profit Growth

aa.aa

+8.27%

+6.93%

+1.82%

-1.67%

-0.13%

Gross Profit Margin %

aa.aa

13.16%

13.09%

11.88%

11.05%

10.71%

Other Operating Expenses, Total

aa.aa

20,941.6

22,213.56

22,348.96

21,096.27

21,910.15

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+10.47%	+6.07%	+0.61%	-5.61%	+3.86%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	1,987.28	2,112.2	2,204.03	2,394.43	2,340.01
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	18,321.14	19,446.64	19,768.07	18,558.32	18,929.86
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	633.18	654.72	376.86	143.51	640.28

Operating Income

aa.aa

7,466.28

8,163.53

8,580.52

9,317.2

8,462.53

Operating Income Growth

aa.aa

+2.53%

+9.34%

+5.11%

+8.59%

-9.17%

EBIT Margin %

aa.aa

3.46%

3.52%

3.3%

3.38%

2.98%

Net Interest Expenses

aa.aa

631.35

-717.86

-1,423.15

-953.92

1,889.22

Net Interest Expenses Growth

aa.aa

+528.41%

-213.7%

-98.25%

+32.97%

+298.05%

Interest Expense, Total

aa.aa

-1,518.23

-1,689.28

-1,884.98

-1,856.74

-1,685.89

Interest And Investment Income

aa.aa

2,149.57

971.41

461.83

902.81

3,575.11

Other Non Operating Expenses, Total

aa.aa

-118.62

-94.93

-98.18

-240.14

-230.08

EBT, Excl. Unusual Items

aa.aa

7,979

7,350.74

7,059.18

8,123.14

10,121.67

Gain (Loss) On Sale Of Assets

aa.aa

58.29

1,438.92

92.48

187.97

157.15

Other Unusual Items, Total

aa.aa

331.74

-200.04

-253.3

-239.05

-462.6

EBT, Incl. Unusual Items

aa.aa

8,143.81

8,808.35

7,054.3

8,020.01

9,819.8

EBT, Incl. Unusual Items Growth

aa.aa

+13.5%

+8.16%

-19.91%

+13.69%

+22.44%

EBT, Incl. Unusual Items Margin

aa.aa

3.77%

3.8%

2.71%

2.91%

3.46%

Income Tax Expense

aa.aa

1,869.25

1,816.34

1,887.73

2,150

2,846.09

Net Income to Company

aa.aa

6,274.57

6,992.01

5,166.57

5,870.01

6,973.72

Minority Interest

aa.aa

-1,181.1

-1,374.86

-1,398.57

-1,317.48

-1,249.16

Net Income

aa.aa

5,093.47

5,617.15

3,768

4,552.53

5,724.56

Net Income Growth

aa.aa

+13.28%

+10.28%

-32.92%

+20.82%

+25.74%

Net Income Margin %

aa.aa

2.36%

2.42%

1.45%

1.65%

2.02%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

5,093.47

5,617.15

3,768

4,552.53

5,724.56

Basic EPS - Continuing Operations

aa.aa

1.79

1.61

1.02

1.23

1.54

Basic EPS - Continuing Operations Growth

aa.aa

+13.28%

-10%

-36.88%

+20.73%

+25.6%

Diluted EPS - Continuing Operations

aa.aa

1.79

1.61

1.02

1.23

1.54

Diluted EPS - Continuing Operations Growth

aa.aa

+13.29%

-10.06%

-36.77%

+20.73%

+25.3%

Basic Weighted Average Shares Outstanding

aa.aa

2,842.09

3,482.74

3,701.29

3,704.06

3,708.31

Diluted Weighted Average Shares Outstanding

aa.aa

2,842.09

3,482.74

3,701.29

3,704.06

3,708.31

Dividend Per Share

aa.aa

0.42

0.61

0.41

0.37

0.47

Dividend Per Share Growth

aa.aa

-12.5%

+45.24%

-32.79%

-9.76%

+27.03%

EBITDA

aa.aa

8,973.04

9,689.36

10,080.96

11,014.77

10,452.47

EBITDA Growth

aa.aa

+2.22%

+7.98%

+4.04%

+9.26%

-5.1%

EBITDA Margin %

aa.aa

4.16%

4.18%

3.87%

3.69%

EBIT

aa.aa

7,466.28

8,163.53

8,580.52

9,317.2

8,462.53

* In Millions of CNY (except for per share items)

FAQ

What was Shanghai Pharma Holding’s revenue at year end?

At the end of the last reported fiscal year, Shanghai Pharma Holding (2607) recorded total revenue of 283,579.60 million CNY.

How much revenue did Shanghai Pharma Holding report in the most recent quarter?

In its most recent quarterly earnings report, Shanghai Pharma Holding posted revenue of 75,261.73 million CNY.

What was Shanghai Pharma Holding’s net income for the year?

For the full year, Shanghai Pharma Holding reported net income of 5,724.56 million CNY.

How much net income did Shanghai Pharma Holding post in the last quarter?

In the most recent quarter, Shanghai Pharma Holding (2607) posted net income of 1,417.76 million CNY.

What was Shanghai Pharma Holding’s gross profit for the year?

Gross profit for the year was reported at 30,372.68 million CNY.

How much gross profit did Shanghai Pharma Holding generate last quarter?

Shanghai Pharma Holding recorded gross profit of 8,092.89 million CNY in its latest quarterly report.

What was Shanghai Pharma Holding’s annual operating income?

For the full year, Shanghai Pharma Holding (2607) reported operating income of 8,462.53 million CNY.

What was Shanghai Pharma Holding’s operating income last quarter?

Quarterly operating income was 2,627.23 million CNY.

What was Shanghai Pharma Holding’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at 3,124.71 million CNY.

What was the quarter-over-quarter change in EBITDA for Shanghai Pharma Holding?

EBITDA changed by 23.18% million CNY compared to the last quarter.

What is Shanghai Pharma Holding’s most recent gross profit margin?

The latest reported gross profit margin for Shanghai Pharma Holding (2607) is 10.75% million CNY.

What is Shanghai Pharma Holding’s most recent net income margin?

Net income margin based on recent financials is 1.88% million CNY.

What is Shanghai Pharma Holding’s most recent EBIT margin?

Shanghai Pharma Holding reported an EBIT margin of 3.49% million CNY based on current figures.

How did Shanghai Pharma Holding’s revenue change compared to the previous quarter?

Revenue changed by 9.86% million CNY compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Shanghai Pharma Holding?

In the latest quarter, gross profit changed by 1.76% million CNY from the previous quarter.

S&P/TSX

36,458.33

+77.10

+0.21%

S&P/TSX 60

2,143.83

+4.73

+0.22%

US 30

53,933.10

-42.5

-0.08%

US 500

7,754.40

+1.4

+0.02%

S&P 500 VIX

15.46

+0.56

+3.76%

DAX

26,323.88

+4.43

+0.02%

Dollar Index

99.65

-0.050

-0.05%

Market Movers

Name	Last	Chg. %	Vol.
Enbridge	71.71	+0.22%	16.34M
RBC	294.09	-0.17%	3.92M
Suncor Energy	87.48	+4.35%	8.21M
Toronto Dominion Bank	168.83	-0.28%	4.18M
Shopify Inc	216.10	+2.24%	3.07M
Celestica Inc.	440.01	-0.79%	1.42M
Bank of Montreal	253.47	+0.09%	2.45M

Name	Last	Chg. %	Vol.
Psyence	0.980	+1,308.05%	100.00
Urban Infra	0.05	+233.33%	500.00K
International Iconic Gold Exploration	0.0150	+200.00%	128.50K
Pharmadrug	0.01	+200.00%	255.50K
Beckett’s	0.01	+200.00%	49.02K
Green Scientific Labs Holdings	0.06	+120.00%	15.00K
Pharmadrug	0.0100	+100.00%	255.50K

Name	Last	Chg. %	Vol.
Lanebury Growth Capital	0.05	-68.75%	18.17K
First Growth Funds	0.02	-57.14%	4.00K
Molecule Holdings	0.005	-50.00%	20.11K
Albert Labs International	0.005	-50.00%	1.00K
Red Lake Gold	0.0500	-50.00%	5.10K
Playground Ventures	0.010	-50.00%	3.00K
Nuinsco Resources	0.0050	-50.00%	427.40K

Trending Stocks

Name	Last	Chg. %	Vol.
Keel Infra	4.73	-12.41%	4.47M
Celestica Inc.	440.01	-0.79%	1.42M
Air Canada	25.75	-3.12%	3.26M
TELUS	13.36	-1.26%	11.60M
Canadian Natural	65.83	+3.75%	5.50M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaa Aaaaaaaaaaa	2.780	+66.95%	4.641
Aaaaa Aaaaaaaa	34.48	+54.85%	53.39
Aaa Aa Aa A A	104.80	+51.67%	158.95
Aaaa Aaa A	141.41	+49.05%	210.77
Aaaaaaaaa	5.23	+47.35%	7.71
Aaaaaa Aa	8.83	+44.39%	12.75
Aaaaaa	4.47	+42.33%	6.36

Name	Last	Upside	Fair Value
Aaa Aaaaaaaaaaa	2.780	+66.95%	4.641
Aaaaa Aaaaaaaa	34.48	+54.85%	53.39
Aaa Aa Aa A A	104.80	+51.67%	158.95
Aaaa Aaa A	141.41	+49.05%	210.77
Aaaaaaaaa	5.23	+47.35%	7.71
Aaaaaa Aa	8.83	+44.39%	12.75
Aaaaaa	4.47	+42.33%	6.36

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Shanghai Pharmaceuticals Holding Co Ltd (2607)

2607 Income Statement

FAQ

What was Shanghai Pharma Holding’s revenue at year end?

How much revenue did Shanghai Pharma Holding report in the most recent quarter?

What was Shanghai Pharma Holding’s net income for the year?

How much net income did Shanghai Pharma Holding post in the last quarter?

What was Shanghai Pharma Holding’s gross profit for the year?

How much gross profit did Shanghai Pharma Holding generate last quarter?

What was Shanghai Pharma Holding’s annual operating income?

What was Shanghai Pharma Holding’s operating income last quarter?

What was Shanghai Pharma Holding’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for Shanghai Pharma Holding?

What is Shanghai Pharma Holding’s most recent gross profit margin?

What is Shanghai Pharma Holding’s most recent net income margin?

What is Shanghai Pharma Holding’s most recent EBIT margin?

How did Shanghai Pharma Holding’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for Shanghai Pharma Holding?

Trending Stocks